Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl S Goodyear

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Expert Opinion on Biological Therapy|March 28, 2026
Personalized psoriatic arthritis therapy: the promise of chromosome conformation signaturesPatricia Riedlova, Carl S Goodyear, Stefan Siebert
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxinCarl S Goodyear, Fujimi Sugiyama, Gregg J Silverman
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxinCarl S Goodyear, Masami Narita, Gregg J Silverman
Transfusion|January 22, 2005
On the mechanism of staphylococcal protein A immunomodulationGregg J Silverman, Carl S Goodyear, Don L Siegel
Journal of Biomolecular Screening|November 25, 2015
Modulation of NF-κB Signaling as a Therapeutic Target in AutoimmunityFelicity D Herrington, Ruaidhrí J Carmody, Carl S Goodyear
Journal of Visualized Experiments : Jove|February 13, 2023
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ MonocytesPatricia Riedlova, Shatakshi Sood, Carl S Goodyear, et al.
Infectious Diseases (London, England)|November 1, 2024
Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies nowAntonio Pagliuca, Sundeep Kaul, Carl S Goodyear, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 17, 2017
Role of Gut Inflammation in Altering the Monocyte Compartment and Its Osteoclastogenic Potential in HLA-B27-Transgenic RatsCecilia Ansalone, Lotta Utriainen, Simon Milling, et al.
Nature Reviews. Rheumatology|January 3, 2023
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapyAurelie Najm, Carl S Goodyear, Iain B McInnes, et al.
Frontiers in Immunology|October 5, 2018
Essential Domain-Dependent Roles Within Soluble IgG for <i>in vivo</i> Superantigen Properties of Staphylococcal Protein A: Resolving the B-Cell Superantigen ParadoxAlejandro J Ulloa-Morales, Carl S Goodyear, Gregg J Silverman
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|March 28, 2026
Personalized psoriatic arthritis therapy: the promise of chromosome conformation signaturesPatricia Riedlova, Carl S Goodyear, Stefan Siebert
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxinCarl S Goodyear, Fujimi Sugiyama, Gregg J Silverman
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxinCarl S Goodyear, Masami Narita, Gregg J Silverman
Transfusion|January 22, 2005
On the mechanism of staphylococcal protein A immunomodulationGregg J Silverman, Carl S Goodyear, Don L Siegel
Journal of Biomolecular Screening|November 25, 2015
Modulation of NF-κB Signaling as a Therapeutic Target in AutoimmunityFelicity D Herrington, Ruaidhrí J Carmody, Carl S Goodyear
Journal of Visualized Experiments : Jove|February 13, 2023
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ MonocytesPatricia Riedlova, Shatakshi Sood, Carl S Goodyear, et al.
Infectious Diseases (London, England)|November 1, 2024
Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies nowAntonio Pagliuca, Sundeep Kaul, Carl S Goodyear, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 17, 2017
Role of Gut Inflammation in Altering the Monocyte Compartment and Its Osteoclastogenic Potential in HLA-B27-Transgenic RatsCecilia Ansalone, Lotta Utriainen, Simon Milling, et al.
Nature Reviews. Rheumatology|January 3, 2023
Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapyAurelie Najm, Carl S Goodyear, Iain B McInnes, et al.
Frontiers in Immunology|October 5, 2018
Essential Domain-Dependent Roles Within Soluble IgG for <i>in vivo</i> Superantigen Properties of Staphylococcal Protein A: Resolving the B-Cell Superantigen ParadoxAlejandro J Ulloa-Morales, Carl S Goodyear, Gregg J Silverman
Pageof 10